# Sam-Sam Association Between EphA2 and SASH1: In Silico Studies of Cancer-Linked Mutations

**Authors:** Marian Vincenzi, Flavia Anna Mercurio, Ida Autiero, Marilisa Leone

PMC · DOI: 10.3390/molecules30030718 · Molecules · 2025-02-05

## TL;DR

This study explores how cancer-linked mutations in the SASH1 protein affect its interaction with EphA2, a key player in cancer, using computational methods.

## Contribution

The paper introduces a multistep computational protocol to analyze how cancer-related mutations in SASH1 affect its interaction with EphA2.

## Key findings

- Cancer-linked mutations in SASH1-Sam1 may destabilize its structure and affect binding to EphA2-Sam.
- Certain mutations are more likely to modulate the SASH1-Sam1/EphA2-Sam interaction.
- AlphaFold2 predictions and molecular dynamics simulations were used to assess structural and functional impacts.

## Abstract

Recently, SASH1 has emerged as a novel protein interactor of a few Eph tyrosine kinase receptors like EphA2. These interactions involve the first N-terminal Sam (sterile alpha motif) domain of SASH1 (SASH1-Sam1) and the Sam domain of Eph receptors. Currently, the functional meaning of the SASH1-Sam1/EphA2-Sam complex is unknown, but EphA2 is a well-established and crucial player in cancer onset and progression. Thus, herein, to investigate a possible correlation between the formation of the SASH1-Sam1/EphA2-Sam complex and EphA2 activity in cancer, cancer-linked mutations in SASH1-Sam1 were deeply analyzed. Our research plan relied first on searching the COSMIC database for cancer-related SASH1 variants carrying missense mutations in the Sam1 domain and then, through a variety of bioinformatic tools and molecular dynamic simulations, studying how these mutations could affect the stability of SASH1-Sam1 alone, leading eventually to a defective fold. Next, through docking studies, with the support of AlphaFold2 structure predictions, we investigated if/how mutations in SASH1-Sam1 could affect binding to EphA2-Sam. Our study, apart from presenting a solid multistep research protocol to analyze structural consequences related to cancer-associated protein variants with the support of cutting-edge artificial intelligence tools, suggests a few mutations that could more likely modulate the interaction between SASH1-Sam1 and EphA2-Sam.

## Linked entities

- **Genes:** SASH1 (SAM and SH3 domain containing 1) [NCBI Gene 23328], EPHA2 (EPH receptor A2) [NCBI Gene 1969]
- **Diseases:** cancer (MONDO:0004992)

## Full-text entities

- **Genes:** SASH1 (SAM and SH3 domain containing 1) [NCBI Gene 23328] {aka CAPOK, DUH, DUH1, SH3D6A, dJ323M4.1}, EPHA2 (EPH receptor A2) [NCBI Gene 1969] {aka ARCC2, CTPA, CTPP1, CTRCT6, ECK}
- **Diseases:** Cancer (MESH:D009369)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11820823/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11820823/full.md

## References

102 references — full list in the complete paper: https://tomesphere.com/paper/PMC11820823/full.md

---
Source: https://tomesphere.com/paper/PMC11820823